CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- 4 Planned sale 10% owner sold 10 shares at $13.73 ($137)
- 4 Other disposition 10% owner disposed of 76,000 shares (other)
- 4 Other disposition 10% owner disposed of 66,500 shares (other)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 388 shares at $18.91 ($7,337)
- 4 Open-market sale Chief Scientific Officer sold 130 shares at $18.92 ($2,460)
- 4 Open-market sale Chief Operating Officer sold 89 shares at $18.92 ($1,684)
- 4 Open-market sale VP, Corporate Controller sold 217 shares at $18.91 ($4,103)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 1,977 shares at $12.64 ($24,989)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 488,090 shares at $25.61 ($12,499,985)
- 4 Open-market buy 10% owner bought 488,090 shares at $25.61 ($12,499,985)
Page 2 of 9 · 173 filings